FindTrial
Sign In

Effect of early inhaled budesonide on the frequency and prognosis of bronchopulmonary dysplasia in preterm infants

Effect of early inhaled budesonide on the frequency and prognosis of bronchopulmonary dysplasia in preterm infants

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000033938
Enrollment
Unknown
Registered
2020-06-18
Start date
2019-01-01
Completion date
Unknown
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchopulmonary Dysplasia

Interventions

Budesonide group:Inhalation of budesonide
Control group:No Interventions

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Infants born before 32wk of gestation, or weighing <1500g who require positive-pressure support ventilation in 24 hours of age.

Exclusion criteria

Exclusion criteria: (1) Receive only palliative care; (2) Have dysmorphic features or congenital abnormalities likely to affect life expectancy or neurological development; (3) Have known or strongly suspected cyanotic heart disease; (4) Meet multiple exclusion criteria.

Design outcomes

Primary

MeasureTime frame
Incidence of bronchopulmonary dysplasia;Mortality rate;—

Secondary

MeasureTime frame
Incidence of necrotizing enterocolitis;Incidence of retinopathy of prematurity;Incidence of brain injury;Incidence of patent ductus arteriosus;Incidence of sepsis;Incidence of gastrointestinal perforation;Incidence of hyperglycemia;Incidence of hypertension;Incidence of oral candidiasis;Days of hospitalization;duration of mechanical ventilation ;Incidence of pneumothorax;—

Countries

China

Contacts

Public ContactLi Fang

Children's Hospital of Chongqing Medical University

rematalili@163.com+86 13512321166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026